Cellular and Molecular Life Sciences CMLS

, Volume 55, Issue 10, pp 1230–1254

The stress-activated protein kinase pathways

  • L. A. Tibbles
  • J. R. Woodgett

DOI: 10.1007/s000180050369

Cite this article as:
Tibbles, L. & Woodgett, J. CMLS, Cell. Mol. Life Sci. (1999) 55: 1230. doi:10.1007/s000180050369


Part of the cellular response to toxins, physical stresses and inflammatory cytokines occurs by signalling via the stress-activated protein kinase (SAPK) and p38 reactivating kinase pathways. This results in modification of cellular gene expression. These stress-responsive kinase pathways are structurally similar, but functionally distinct, from the archetypal mitogen-activated protein kinases (MAPKs or ERKs). The ERK pathway is a hierarchical cascade originating at the cell membrane with receptors for mitogens or growth factors, which recruit, via adapter proteins and exchange factors, the small guanosine triphosphatase (GTPase) Ras (see fig. 1). Ras activates raf, a serine threonine kinase, which activates MEK (MAPK/ERK kinase). MEK, in turn, phosphorylates and activates ERK1 and ERK2, which translocate to the nucleus and transactivate transcription factors, changing gene expression to promote growth, differentiation or mitosis. By transducing signals through a cascade of kinases, several options for control are introduced for amplifying and/or modifying the output signal. The SAPK and p38 pathways are also hierarchically arranged, but less is known about the upstream components and the downstream effects of stimulation of these pathways. Among the processes modulated by stress-responsive pathways are apoptosis, transformation, development, immune activation, inflammation and adaptation to environmental changes. This review outlines the upstream componentry of these pathways that interact with a variety of agonists to modify the activity of SAPK and p38, and explores the downstream functions of this activation.

Key words. Stress-activated protein kinase (SAPK); jun N-terminal kinase (JNK); p38; mitogen activated protein kinase (MAPK); apoptosis. 

Copyright information

© Birkhäuser Verlag Basel, 1999

Authors and Affiliations

  • L. A. Tibbles
    • 1
  • J. R. Woodgett
    • 1
  1. 1.Division of Experimental Therapeutics, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario M5G 2M9 (Canada), Fax +1 416 946 2984, e-mail: jwoodget@oci.utoronto.caCA

Personalised recommendations